"Executive Summary Prostate Cancer Antigen 3 (PCA3) Test Market :  Data Bridge Market Research analyses that the prostate cancer antigen 3 (PCA3) test market which was USD 3.2 billion in 2021, is expected to reach USD 7.64 billion by 2029, at a CAGR of 11.50% during the forecast period 2022 to 2029.   The Prostate Cancer Antigen 3 (PCA3) Test Market report has been...